NCT01359930View on ClinicalTrials.gov

Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Methamphetamine Dependence
Interventions
OTHER

placebo

matching placebo

DRUG

Naltrexone and Bupropion SR

25mg bid/day (NX) 200mg bid/day (BUP)

Trial Locations (1)

94143

Langley Porter Psychiatric Institute, San Francisco

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT01359930 - Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study | Biotech Hunter | Biotech Hunter